[Utility of hCG dosage in the management of gestational trophoblastic diseases]

Alban Gildas Comlan Zohoun1, Karl Hounmenou1, Samira El Idrissi Mechtani1

  • 1Laboratoire de biochimie-toxicologie, Hôpital militaire d'instruction Mohammed V, Rabat, Maroc.

Insights

Monitoring human chorionic gonadotropin (hCG) is crucial for diagnosing and managing gestational trophoblastic diseases (GTD). Rigorous hCG level monitoring during treatment and follow-up significantly improves patient outcomes and disease prognosis.

Area of Science:

  • Reproductive Endocrinology
  • Gynecologic Oncology
  • Clinical Chemistry

Background:

  • Human chorionic gonadotropin (hCG) measurement is fundamental for the diagnosis, treatment, and follow-up of gestational trophoblastic diseases (GTD).
  • Gestational trophoblastic diseases represent a spectrum of pregnancy-related tumors requiring precise management strategies.

Purpose of the Study:

  • To evaluate the contribution of hCG measurement in the diagnosis, treatment, and follow-up of GTD.
  • To assess the prognostic value of hCG monitoring in patients with GTD.

Main Methods:

  • A prospective cohort study was conducted over 18 months.
  • 35 patients diagnosed with GTD were included.
  • hCG levels were measured using electrochemiluminescence.

Main Results:

  • The overall frequency of GTD was 0.33 per 100 childbirths.
  • 26 patients presented with abnormal hCG levels (>200,000 UI/mL).
  • 73.5% of patients treated with uterine aspiration experienced favorable outcomes with normalized hCG levels within 3-13 weeks.
  • 9 patients had unfavorable outcomes, including relapse or hCG stagnation.

Conclusions:

  • Rigorous monitoring of hCG levels is essential for improving the prognosis of GTD.
  • Consistent hCG surveillance aids in early detection of relapse and guides treatment adjustments.
  • Effective management of GTD relies on precise and timely hCG quantification.

Related Concept Videos

Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.4K
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
3.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K